Tag: licensing
-
Univ. Lab Licenses Protein for Vaccine Patch
A company developing a needle patch for vaccine delivery is acquiring the rights to a synthetic SARS-Cov-2 spike protein for its Covid-19 vaccine patch.
-
Drug Discovery Biotech Inks Partnering Deal, Gains $175M
A biotechnology company discovering protein therapies in fungi is collaborating with drug maker GlaxoSmithKline to find new small molecule drugs.
-
Synthetic Antibodies to be Designed with Organoids
A biotechnology enterprise plans to discover synthetic antibodies with 3-D printed lymph node tissue for future licensing to a pharma company.
-
Covid-19 Nasal Vaccine Produces Antibodies, Cuts Viral Load
Tests with lab animals show a vaccine given as a nasal spray produces high antibody volumes against SARS-CoV-2 infections and reduces viral loads.
-
Pharma Company Licenses Protein Delivery Hydrogel
A drug maker acquired commercialization rights to an injectable hydrogel developed at a university lab that delivers proteins to repair diseased tissue.
-
University Lab Licenses Printed Kidney Tissue Process
A start-up company is acquiring the rights to a stem cell and three-dimensional printing process to produce tissue needed by people with kidney failure.
-
Trial Shows Immunotherapy Improves Lung Cancer Survival
Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy.
-
Biotech Partners on Gene Editing Tech in $1.35B Deal
A biotechnology company is making its precise gene editing technology available to drug maker Pfizer for rare diseases, in a deal valued at $1.35 billion.
-
Bio-Based Material Shown to Aid Tendon Repair
Academic and industry researchers demonstrated in lab animals a tough material derived from natural sources that speeds repair of injured tendons.
-
India Authorizes Covid-19 Vaccines Designed in US
The government of India granted emergency clearance to two vaccines to prevent Covid-19 disease, both designed in U.S. research labs.